TRAPPC4

TRAPPC4 is a core subunit of the multimeric TRAPP complex that drives intracellular membrane trafficking and is co-opted in cancer to control immune evasion, proliferation, and ferroptosis resistance (PMID:31794024, PMID:34518538). As a TRAPP subunit it is required for guanine nucleotide exchange activity toward the Rab1 GTPase, and its loss disrupts TRAPP complex assembly/stability, delaying ER-to-Golgi and intra-Golgi trafficking and impairing basal autophagy and autophagic flux; a splice variant (c.454+3A>G) reduces full-length protein and causes these defects, which are reversed by wild-type re-expression (PMID:31794024). In tumor cells TRAPPC4 acts as a scaffold linking PD-L1 to RAB11 in recycling endosomes, promoting RAB11-mediated recycling of PD-L1 to the cell surface, an interaction enhanced by PD-L1 acetylation (PMID:34518538, PMID:37603071). Independently, TRAPPC4 binds ERK2 and governs the nuclear accumulation of phospho-ERK1/2, thereby promoting cell-cycle progression and viability while its depletion induces G0/G1 arrest, p21 upregulation, and apoptosis in colorectal cancer cells (PMID:21826244, PMID:23625650). TRAPPC4 also confers ferroptosis resistance by reducing chromatin accessibility at a regulatory element upstream of TRIM55, limiting FOS-dependent TRIM55 transcription and thereby suppressing TRIM55-mediated ubiquitination and degradation of GPX4 (PMID:41974002).

1. 2011 Medium

   Established that TRAPPC4 is not solely a trafficking factor but physically engages the MAPK pathway, defining a route by which it influences proliferation and survival.

   Evidence Yeast two-hybrid, Co-IP, and GST pull-down for ERK2 binding with subcellular fractionation and knockdown/overexpression in colorectal cancer cells

   PMID:21826244

   Open questions at the time

   • Direct binding region/interface on TRAPPC4 not mapped
   • Mechanism by which TRAPPC4 controls nuclear pERK localization unresolved
   • Single lab
2. 2013 Medium

   Connected the TRAPPC4-ERK2 axis to defined cell-cycle control, showing TRAPPC4 is required for EGF-driven pERK2 nuclear translocation and proliferation in vivo.

   Evidence siRNA/overexpression, cell cycle analysis, IHC, and xenograft models with EGF stimulation

   PMID:23625650

   Open questions at the time

   • Does not establish whether trafficking role and ERK role are mechanistically coupled
   • Single lab
3. 2020 High

   Defined the conserved core mechanism: TRAPPC4 is a TRAPP subunit required for Rab1 GEF activity and complex stability, linking its loss to secretory and autophagy defects in human disease.

   Evidence Native PAGE/SEC complex assembly, VSVG-GFP-ts045 trafficking assay, autophagy flux, lentiviral complementation in patient fibroblasts, and yeast trs23 genetic model

   PMID:31794024

   Open questions at the time

   • Structural detail of how TRAPPC4 contributes to GEF catalysis not resolved
   • Specific neurological disease entity not detailed here
4. 2021 High

   Revealed a cancer-specific membrane-trafficking role: TRAPPC4 scaffolds PD-L1 to RAB11 for recycling-endosome return to the surface, implicating it in tumor immune evasion.

   Evidence Reciprocal Co-IP, subcellular fractionation, knockdown/overexpression with PD-L1 surface readout, and in vivo tumor models

   PMID:34518538

   Open questions at the time

   • Binding interface between TRAPPC4 and PD-L1 not mapped
   • Relationship to core TRAPP/Rab1 function unclear
5. 2023 Medium

   Extended the recycling model by showing PD-L1 acetylation increases its TRAPPC4 association and surface localization in pancreatic cancer.

   Evidence HDAC inhibitor (VPA) treatment, Co-IP of acetylated PD-L1 with TRAPPC4, and flow cytometry for surface PD-L1

   PMID:37603071

   Open questions at the time

   • No mutagenesis of acetylation sites to confirm causality
   • Single Co-IP under pharmacological perturbation
   • Single lab
6. 2026 High

   Identified a transcription/chromatin-linked function whereby TRAPPC4 limits TRIM55 expression to stabilize GPX4 and confer ferroptosis resistance, and nominated a druggable handle.

   Evidence Genome-wide CRISPR knockout screen, ATAC-seq, ubiquitination assays, organoids/CDX/PDX and conditional KO mice, plus structure-based screening identifying pitavastatin calcium

   PMID:41974002

   Open questions at the time

   • Mechanism by which a trafficking subunit modulates chromatin accessibility unexplained
   • Direct DNA/chromatin association of TRAPPC4 not demonstrated

• How TRAPPC4's conserved TRAPP/Rab1 trafficking function mechanistically relates to its distinct roles in ERK nuclear signaling, PD-L1 recycling, and TRIM55/GPX4-mediated ferroptosis resistance remains unresolved.
• No unifying model connecting the trafficking, signaling, and chromatin roles
• Structural basis of non-TRAPP interactions undefined